Clinical Trial Data Review for PBC Therapeutics, Including Dual Peroxisome Activated Receptor (PPAR) Alpha/Delta Agonists

Oct 7, 2024

- Oct 6, 2025

0.5

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

Already have an Account? Log In
Don’t have an account? Register Today

Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiolog...

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Pati...

ATTRv-PN: Advances in Understanding and Managing Amyloid Disease with Peripheral Neuropath...